Tonix enrolls first patient in Phase 2 MDD study of TNX-102 SL

June 29, 2026 7:25 AM

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced that the first patient has been enrolled in HORIZON, a Phase 2 clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found